Meeting
2014 ASCO Annual Meeting
Role of serum lipids and glucose as biomarkers of prostate cancer severity.
Authors
Alejo Rodriguez-Vida
Medical Oncology department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
Alejo Rodriguez-Vida , Rhonda Arthur , Aida Santaolalla , Deborah Enting , Lars Holmberg , Simon Chowdhury , Sarah Maria Rudman , Prokar Dasgupta , Tim S. O'Brien , Janette Kinsella , Mieke Van Hemelrijck , Declan Cahill
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 5080)
DOI
10.1200/jco.2014.32.15_suppl.5080
Abstract #
5080
Poster Bd #
209
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Association of health-related quality of life (HRQOL) variations with biological biomarkers for patients with metastatic castrate-resistant prostate cancer (MCRPC) treated by abiraterone/prednisone combination or prednisone.
First Author: Morgan Goujon
Poster
2020 Genitourinary Cancers Symposium
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS).
First Author: Anna Lantz
Poster
2020 Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) of metastatic castrate-sensitive prostate cancer (mCSPC) to reveal potential biomarkers and therapeutic targets.
First Author: Di Maria Jiang
Poster
2019 ASCO Annual Meeting
Interim results from a phase 2 study of olaparib (without ADT) in men with biochemically-recurrent prostate cancer after prostatectomy, with integrated biomarker analysis.
First Author: Emmanuel S. Antonarakis